We have previously reported that the increased expression of LAMP-2 in liver correlated with the severity of PBC, and UDCA treatment may partially improve the recovery of LAMP-222, suggesting augmented expression of LAMP-2 may assist in the progress of PBC and predict a poor outcome in patients with PBC. Here, LAMP2 is linked to primary biliary cholangitis.